Test Development Sample Clauses
The Test Development clause outlines the responsibilities and procedures for creating, designing, and implementing tests or assessments within an agreement. Typically, it specifies which party is responsible for developing the test materials, the standards or criteria the tests must meet, and any timelines or approval processes involved. For example, it may require that all test content be reviewed and approved by both parties before use. This clause ensures that the development of tests is managed systematically, maintains quality and consistency, and clarifies accountability, thereby reducing misunderstandings and disputes over test creation.
Test Development. The parties shall mutually agree on the content and composition of Phase II of the Assay, and any Collaboration Assays as defined in Section 3.5(f), including specific analytes to be included in the Assay. Consideration for selection of analytes shall include medical need, clinical utility, technical feasibility, costs, reimbursement, and intellectual property status, e.g., the need for Third Party licenses to specific analytes. The parties shall agree on the Phase II Assay content at least six (6) months before anticipated Launch.
Test Development. The surface treated sample shall pass a salt-spray test, in which the sample and any components with which is normally in contact are put in upright position into the salt- spray test equipment. The wheel is turned through 90° every 48 hours.
Test Development. Sharp shall pay for the cost of test development and test equipment in the manufacturing process, unless otherwise agreed by the Parties in writing. Notwithstanding the foregoing, Danger shall, at its expense, provide factory diagnostic testing software for the M-1 Product. [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.